ATE210118T1 - N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten - Google Patents
N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonistenInfo
- Publication number
- ATE210118T1 ATE210118T1 AT94927076T AT94927076T ATE210118T1 AT E210118 T1 ATE210118 T1 AT E210118T1 AT 94927076 T AT94927076 T AT 94927076T AT 94927076 T AT94927076 T AT 94927076T AT E210118 T1 ATE210118 T1 AT E210118T1
- Authority
- AT
- Austria
- Prior art keywords
- alanine derivatives
- piperidinylcarbonyl
- inhibitor
- paf antagonists
- blood platelets
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939319561A GB9319561D0 (en) | 1993-09-22 | 1993-09-22 | Beta-alanine derivative and a process for preparation thereof |
| GB9413936A GB9413936D0 (en) | 1994-07-11 | 1994-07-11 | Beta-Alanine derivative and a process for the preparation thereof |
| PCT/JP1994/001550 WO1995008536A1 (en) | 1993-09-22 | 1994-09-21 | N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE210118T1 true ATE210118T1 (de) | 2001-12-15 |
Family
ID=26303555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94927076T ATE210118T1 (de) | 1993-09-22 | 1994-09-21 | N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6380215B1 (de) |
| EP (2) | EP0669912B1 (de) |
| CN (1) | CN1041919C (de) |
| AT (1) | ATE210118T1 (de) |
| AU (1) | AU684547B2 (de) |
| CA (1) | CA2157792C (de) |
| DE (1) | DE69429328T2 (de) |
| DK (1) | DK0669912T3 (de) |
| ES (1) | ES2164109T3 (de) |
| HU (1) | HUT73174A (de) |
| IL (3) | IL111036A (de) |
| PT (1) | PT669912E (de) |
| RU (1) | RU2161155C2 (de) |
| TW (1) | TW401414B (de) |
| WO (1) | WO1995008536A1 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010051730A1 (en) * | 1993-09-22 | 2001-12-13 | Fujisawa Pharmaceutical Co., Ltd. | Beta-alanine derivative and a process for the preparation thereof |
| CA2215106A1 (en) * | 1995-03-17 | 1996-09-26 | Fujisawa Pharmaceutical Co., Ltd. | N-acylpiperidinylcarbonylaminocarboxylic acids and their use as glycoprotein iib/iiia antagonists and fibrinogen-blood platelets binding inhibitors |
| KR19990087694A (ko) * | 1996-03-13 | 1999-12-27 | 후지야마 아키라 | 피브리노겐 수용체 길항제로서의 N-[(R)-１-{３-(４-피페리딜)프로피오닐-３-피페리딜카보닐]-２(S)-아세틸아미노-β-알라닌 |
| PT923555E (pt) * | 1996-05-01 | 2005-09-30 | Ortho Mcneil Pharm Inc | Derivados carboxamida de pirrolidina, piperidina e hexa-hidroazepina para o tratamento de disturbios tromboticos |
| EP1184374B1 (de) * | 1996-05-01 | 2009-01-28 | Ortho-McNeil Pharmaceutical, Inc. | Carboxamidderivate von Pyrrolidin, Piperidin und Hexahydropiperizin für Behandlung von Thrombosen |
| EP1000030A1 (de) * | 1997-07-14 | 2000-05-17 | Phytera Symbion ApS | Piperidin-oligomeren und diese enthaltende kombinatorische bibliotheken |
| US6066651A (en) | 1997-10-29 | 2000-05-23 | Ortho-Mcneil Pharmaceutical, Inc. | Orally-active nipecotamide glycolamide esters for the treatment of thrombosis disorders |
| US6020347A (en) * | 1997-11-18 | 2000-02-01 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
| AU1415099A (en) * | 1997-11-18 | 1999-06-07 | Merck & Co., Inc. | 4-substituted-4-piperidine carboxamide derivatives |
| AU769718B2 (en) * | 1998-10-12 | 2004-02-05 | Fujisawa Pharmaceutical Co., Ltd. | New processes for producing beta-alanine derivative |
| AUPP646598A0 (en) * | 1998-10-12 | 1998-11-05 | Fujisawa Pharmaceutical Co., Ltd. | New processes for producing alpha-alanine derivative |
| MXPA01009615A (es) * | 1999-03-22 | 2003-07-21 | Johnson & Johnson | Procedimiento para la preparacion de acido [s -(r*s*)] -°-[[[1[1- oxo-3 -(4-piperidinil) propil]3 -piperidini] carbonil] amino] -3-piridinil] carbonil] amino] -3-piridinpropanoico, y derivados del mismo. |
| DE60021521T4 (de) | 1999-09-29 | 2006-09-21 | Ortho-Mcneil Pharmaceutical, Inc. | Isonipecotamide zur behandlung von integrin vermittelten störungen |
| AUPQ570100A0 (en) * | 2000-02-17 | 2000-03-09 | Fujisawa Pharmaceutical Co., Ltd. | Beta-alanine derivatives and their use as receptor antagonists |
| US7081460B2 (en) | 2001-04-09 | 2006-07-25 | Ortho-Mcneil Pharmaceutical, Inc. | Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| EP2404899A1 (de) | 2004-02-25 | 2012-01-11 | Astellas Pharma Inc. | Kontrastmittel für Thrombusentdeckung |
| US9345793B2 (en) | 2011-08-17 | 2016-05-24 | Piramal Imaging Sa | Compounds for binding to the platelet specific glycoprotein IIB/IIIA and their use for imaging of thrombi |
| CA2900595A1 (en) | 2013-02-12 | 2014-08-21 | Bayer Pharma Aktiengesellschaft | Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia |
| KR102548998B1 (ko) | 2020-03-31 | 2023-06-29 | 재단법인 아산사회복지재단 | 혈전영상을 위한 방사성의약품 및 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03257624A (ja) * | 1990-03-08 | 1991-11-18 | Fujitsu Ltd | 画面言語方式 |
| CA2037153A1 (en) * | 1990-03-09 | 1991-09-10 | Leo Alig | Acetic acid derivatives |
| CA2054627A1 (en) * | 1991-02-13 | 1992-08-14 | Yea-Shun Cheng | Polypeptide skeletal muscle relaxants |
| FI934894A0 (fi) * | 1991-05-07 | 1993-11-05 | Merck & Co Inc | Fibrinogenreceptorantagonister |
| US5770575A (en) * | 1994-03-16 | 1998-06-23 | Ortho Pharmaceutical Corporation | Nipecotic acid derivatives as antithrombotic compounds |
-
1994
- 1994-09-21 RU RU95112456/04A patent/RU2161155C2/ru not_active IP Right Cessation
- 1994-09-21 HU HU9501845A patent/HUT73174A/hu unknown
- 1994-09-21 CA CA002157792A patent/CA2157792C/en not_active Expired - Lifetime
- 1994-09-21 DE DE69429328T patent/DE69429328T2/de not_active Expired - Lifetime
- 1994-09-21 WO PCT/JP1994/001550 patent/WO1995008536A1/en not_active Ceased
- 1994-09-21 PT PT94927076T patent/PT669912E/pt unknown
- 1994-09-21 US US08/495,572 patent/US6380215B1/en not_active Expired - Lifetime
- 1994-09-21 TW TW083108696A patent/TW401414B/zh not_active IP Right Cessation
- 1994-09-21 CN CN94190981A patent/CN1041919C/zh not_active Expired - Fee Related
- 1994-09-21 DK DK94927076T patent/DK0669912T3/da active
- 1994-09-21 AU AU76657/94A patent/AU684547B2/en not_active Ceased
- 1994-09-21 AT AT94927076T patent/ATE210118T1/de not_active IP Right Cessation
- 1994-09-21 ES ES94927076T patent/ES2164109T3/es not_active Expired - Lifetime
- 1994-09-21 EP EP94927076A patent/EP0669912B1/de not_active Expired - Lifetime
- 1994-09-21 EP EP01102827A patent/EP1106606A3/de not_active Withdrawn
- 1994-09-22 IL IL11103694A patent/IL111036A/xx not_active IP Right Cessation
- 1994-09-22 IL IL12682594A patent/IL126825A/xx not_active IP Right Cessation
-
1998
- 1998-10-30 IL IL12682598A patent/IL126825A0/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0669912T3 (da) | 2002-03-04 |
| IL111036A0 (en) | 1994-11-28 |
| CN1041919C (zh) | 1999-02-03 |
| WO1995008536A1 (en) | 1995-03-30 |
| EP1106606A3 (de) | 2003-10-22 |
| EP0669912B1 (de) | 2001-12-05 |
| EP0669912A1 (de) | 1995-09-06 |
| HK1004985A1 (en) | 1998-12-18 |
| DE69429328D1 (de) | 2002-01-17 |
| DE69429328T2 (de) | 2002-06-13 |
| CA2157792C (en) | 2005-05-24 |
| HU9501845D0 (en) | 1995-08-28 |
| CA2157792A1 (en) | 1995-03-30 |
| EP1106606A2 (de) | 2001-06-13 |
| IL126825A (en) | 1999-09-22 |
| AU7665794A (en) | 1995-04-10 |
| CN1116847A (zh) | 1996-02-14 |
| ES2164109T3 (es) | 2002-02-16 |
| TW401414B (en) | 2000-08-11 |
| AU684547B2 (en) | 1997-12-18 |
| RU2161155C2 (ru) | 2000-12-27 |
| IL126825A0 (en) | 1999-08-17 |
| HUT73174A (en) | 1996-06-28 |
| IL111036A (en) | 1999-07-14 |
| US6380215B1 (en) | 2002-04-30 |
| RU95112456A (ru) | 1997-04-20 |
| PT669912E (pt) | 2002-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69429328D1 (de) | N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten | |
| EA200300776A1 (ru) | Производные фенэтаноламина для лечения респираторных заболеваний | |
| EA200400432A1 (ru) | Производные мочевины | |
| CY1108367T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
| BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
| NO882036L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske ketoner. | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| BR9910119A (pt) | Derivados heterocìclicos de glicil beta-alanina como antagonistas de vitronectina | |
| EE200300403A (et) | N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina | |
| BRPI0418102A (pt) | derivados de quinolina | |
| DE69716823D1 (de) | Thrombin-Inhibitoren als anticoagulierende Mittel | |
| WO2005056524A3 (en) | Therapeutic agents useful for treating pain | |
| NO985518D0 (no) | Morfinanderivater og medisinsk anvendelse derav | |
| ATE268337T1 (de) | C11-carbamate von antibakteriellen makroliden | |
| DE69834500D1 (de) | Xanthinderivative zur behandlung von hirnischämie | |
| EA200301203A1 (ru) | Новые соединения и композиции как ингибиторы катепсина | |
| MD1560F2 (en) | Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses. | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| DE69315699D1 (de) | Inhibitoren gegen die aggregation von blutplättchen | |
| DE69925270D1 (de) | Mittel zur linderung von juckreiz, enthaltend pgd2- antagonisten | |
| DE69931378D1 (de) | Chinazolin derivate und therapeutische verwendungen davon | |
| ATE187956T1 (de) | Substituierte kondensierte und verbrückte bicyclische verbindungen als therapeutische mittel | |
| SE0102058D0 (sv) | New Salts II | |
| DE69503760D1 (de) | Kaliumsalz eines biphenylmethanderivates und dasselbe enthaltendes medikament | |
| DE69908855D1 (de) | 9a, 11b-dehydro Derivative von 9-oxime-3-keto-6-0-methylerythromycin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |